You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
We will want to consider in our object model how we can account for transformations between compounds and transformations between protein variants (i.e. mutations).
We will also want to consider how we might present the results of computed mutations for various compounds on the dashboard. For example, @dotsdl suggests the Compounds page could show a grid of computed point mutation free energies reminiscent of this plot from https://www.biorxiv.org/content/10.1101/2022.01.26.477860v2, which could show the impact of the mutation on the inhibitor binding affinity (reduces affinity, netural, increases affinity, or not computed). We could also summarize the key mutations and key residues that, when mutated, most strongly ablate affinity.
In most uses, only a subset of these mutations will be computed, and only for a subset of compounds.
The text was updated successfully, but these errors were encountered:
jchodera
changed the title
Consider how we will account for relative mutation free energies
Thoughts on integrating protein mutations into calculation framework and dashboard
Feb 7, 2022
We will want to consider in our object model how we can account for transformations between compounds and transformations between protein variants (i.e. mutations).
We will also want to consider how we might present the results of computed mutations for various compounds on the dashboard. For example, @dotsdl suggests the Compounds page could show a grid of computed point mutation free energies reminiscent of this plot from https://www.biorxiv.org/content/10.1101/2022.01.26.477860v2, which could show the impact of the mutation on the inhibitor binding affinity (reduces affinity, netural, increases affinity, or not computed). We could also summarize the key mutations and key residues that, when mutated, most strongly ablate affinity.
In most uses, only a subset of these mutations will be computed, and only for a subset of compounds.
The text was updated successfully, but these errors were encountered: